Unrelated Donor Transplantation for Acute Myelogenous Leukemia in First Remission

We retrospectively analyzed the outcomes of all acute myelogenous leukemia (AML) patients in first remission (n = 44; median age = 48 years; high-risk cytogenetics = 59%) who received unrelated donor hematopoietic cell transplantation (HCT) with myeloablative conditioning regimen of i.v. busulfan, f...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Bashir, Qaiser, Andersson, Borje S., Fernandez-Vina, Marcelo, de Padua Silva, Leandro, Giralt, Sergio, Chiattone, Alexandre, Wei, Wei, Sharma, Manish, Anderlini, Paolo, Shpall, Elizabeth J., Popat, Uday, Rodrigues, Morgani, Champlin, Richard E., de Lima, Marcos
Formato: Artigo
Idioma:Inglês
Publicado em: 2010
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4080632/
https://ncbi.nlm.nih.gov/pubmed/21087679
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2010.11.012
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados